Robert Gilbert, MD
To the editors: Callahan and colleagues (1) did a meta-analysis of a 40-year-old problem: the value of corticosteroids in stable, chronic obstructive pulmonary disease (COPD). This study is definitive but will probably change no one's mind; those who advocate corticosteroid therapy will cite the positive result, whereas those who do not advocate it will point out the minimal benefit of the therapy when considered in the light of corticosteroid side effects. In the 15 studies that qualified for analysis, no patient received less than 30 mg of prednisone per day or its equivalent, and the average daily dose was the
Gilbert R. Corticosteroids for Chronic Obstructive Pulmonary Disease. Ann Intern Med. ;114:704. doi: 10.7326/0003-4819-114-8-704_1
Download citation file:
Published: Ann Intern Med. 1991;114(8):704.
Chronic Obstructive Airway Disease, Pulmonary/Critical Care.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use